No Data
No Data
InspireMD Brings in $17.9M to Support Stent Trial
InspireMD Secures Funds to Expand Healthcare Innovations
Express News | InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
Express News | InspireMD: Files Prospectus Supplement to Offer, Sell Common Stock of up to $17 Mln From Time to Time Under Equity Distribution Deal With Piper Sandler
InspireMD's CGuard Stent Shows Promise in C-GUARDIANS Trial
Express News | InspireMD Presents One-Year Follow-Up Results From C-GUARDIANS US IDE Trial Of CGuard At LINC 2024 On May 28 At 8:53 A.m. EDT
No Data